Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Polygenic Risk Score to Optimize Primary Prevention in Intermediate Risk Population (PERSONAL)

NCT07039123 is registered in ClinicalTrials.gov with University of Bern as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07039123 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Polygenic Risk Score to Optimize Primary Prevention in Intermediate Risk Population (PERSONAL)
Lead sponsor
University of Bern
Phase
Not applicable
Overall status
Active, not recruiting
Start date
July 8, 2025
Completion date
November 8, 2027
Enrollment
205 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

primary prevention of cardiovascular disease